Publications by authors named "R Chiari"

Claim this Profile
C
Crizotinib in Patients With -Positive NSCLC With or Without Brain Metastases: Post Hoc Analysis of Phase II METROS Trial.
Lorenza Landi, Rita Chiari, Marcello Tiseo, Giulio Metro, Filippo de Marinis

JTO Clin Res Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase III randomized clinical trial of Gemcitabine and Nab-Paclitaxel as switch maintenance versus continuation of modified FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: The PANThEON Study.
Carolina Sciortino, Federico Nichetti, Francesca Bergamo, Federica Palermo, Stefano Tamberi, Rita Chiari

Dig Liver Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant atezolizumab in surgically resected NSCLC patients with PD-L1 expression ≥50%: real-world data from the italian ATLAS registry.
Francesco Passiglia, Maria Lucia Reale, Giulia Pasello, Giuseppe Viscardi, Ilaria Attili, Rita Chiari

Oncologist· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exceptional responses to Trastuzumab deruxtecan in HER2-positive breast cancer: two illustrative case reports.
Zelmira Ballatore, Helene Vanacker, Rita Chiari, Thomas Bachelot

Front Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PI3K/mTORC2-RICTOR axis in early squamous non-small-cell lung cancer: genomics, molecular expression, and clinical relevance.
Sara Pilotto, Lorenzo Belluomini, Federico Monaca, Michele Simbolo, Antonio Agostini, Rita Chiari

Ther Adv Med Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis